HomeAI · summaries
Storia in 4 fonti
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
gizmodo.com
Can Ozempic Treat Alcoholism? Here's What You Should Know
A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.
- ·
scientificamerican.com
New powerful GLP-1 drugs drop a lot of weight fast. How does that affect health?
New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?
- ·
hindustantimes.com
Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks
GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News
- ·
sciencedaily.com
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also…